| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $216.7M | -2.9% |
| Cost of Revenue | $126.4M | -5.4% |
| R&D Expense | $175.1M | +13.3% |
| SG&A Expense | $80.9M | +14.8% |
| Operating Income | -$170.1M | -25.6% |
| Interest Expense | $9.3M | +7.0% |
| Pre-tax Income | -$146.1M | -9.6% |
| Income Tax | -$1.9M | +57.6% |
| Net Income | -$132.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $274.2M | +80.8% |
| Accounts Receivable | $52.0M | -18.2% |
| Inventory | $49.9M | +50.5% |
| Current Assets | $408.7M | +50.4% |
| Total Assets | $941.4M | +15.0% |
| Current Liabilities | $84.9M | -38.9% |
| Long-term Debt | $381.3M | +137.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$58.6M | +43.9% |
| Capital Expenditures | $14.3M | +12.4% |
| Investing Cash Flow | -$19.3M | +82.1% |
| Financing Cash Flow | $209.3M | +380.5% |
| Free Cash Flow | -$72.9M | +37.7% |
| -12.7% |
| EPS (Basic) | -$0.76 | +6.2% |
| EPS (Diluted) | -$0.76 | +6.2% |
| Total Liabilities |
| $496.0M |
| +45.1% |
| Stockholders' Equity | $417.9M | -6.3% |